Cytek Biosciences, Inc. (CTKB)
- Previous Close
5.32 - Open
5.29 - Bid 5.33 x 200
- Ask 5.36 x 200
- Day's Range
5.25 - 5.47 - 52 Week Range
3.80 - 9.87 - Volume
649,924 - Avg. Volume
619,925 - Market Cap (intraday)
702.242M - Beta (5Y Monthly) 1.31
- PE Ratio (TTM)
-- - EPS (TTM)
-0.14 - Earnings Date Aug 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
8.10
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
cytekbio.comRecent News: CTKB
View MorePerformance Overview: CTKB
Trailing total returns as of 10/15/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CTKB
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CTKB
View MoreValuation Measures
Market Cap
702.24M
Enterprise Value
438.80M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.59
Price/Book (mrq)
1.80
Enterprise Value/Revenue
2.22
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-8.88%
Return on Assets (ttm)
-3.01%
Return on Equity (ttm)
-4.32%
Revenue (ttm)
197.71M
Net Income Avi to Common (ttm)
-17.56M
Diluted EPS (ttm)
-0.14
Balance Sheet and Cash Flow
Total Cash (mrq)
277.21M
Total Debt/Equity (mrq)
3.54%
Levered Free Cash Flow (ttm)
30.25M